Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription 06.10.2025 1 Antimicrob Agents Chemother 1 Antiviral Res 6 BMC Pediatr 1 Cell 1 J Immunol 1 J Virol 3 MMWR Morb Mortal Wkly Rep 1 N Engl J Med 1 Pediatrics 3 PLoS Comput Biol 1 PLoS Med 24 PLoS One 7 Proc Natl Acad Sci U S A 4 Vaccine 4 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. WU Q, Lv L, Yan S, Wang Y, et al
   A first-in-human phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel anti-influenza agent suraxavir marboxil in healthy Chinese subjects.
   Antimicrob Agents Chemother. 2025 Sep 30:e0068525. doi: 10.1128/aac.00685.
   PubMed         Abstract available
   
   

   
   Antiviral Res

2. ZHANG W, Prevost J, Sloan A, Tamming L, et al
   Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses.
   Antiviral Res. 2025;243:106284.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

3. LILLIEBERG E, Ertzgaard P, Fernlund E, Duchen K, et al
   Experiences of living with long COVID during childhood and adolescence: a qualitative study from the child's perspective.
   BMC Pediatr. 2025;25:754.
   PubMed         Abstract available
   
   
4. KALASIKAM M, Jimenez-Truque N, Kloek AB, Banerjee R, et al
   Antibiotic overuse in a contemporary cohort of children hospitalized with influenza, RSV, or SARS-CoV-2: a retrospective cohort study.
   BMC Pediatr. 2025;25:759.
   PubMed         Abstract available
   
   
5. SARAF R, Dowell T, Stubbe M, Marsh S, et al
   New Zealand school children's perspectives on influenza: listening to young voices in respiratory health.
   BMC Pediatr. 2025;25:740.
   PubMed         Abstract available
   
   
6. XIONG S, Guo Y, Jiang L, Wang Y, et al
   A simple, rapid, and cost-effective model for predicting critical influenza a infection in children: a multicentre, retrospective cohort study.
   BMC Pediatr. 2025;25:746.
   PubMed         Abstract available
   
   
7. HUANG S, Chen J, Li F, Li W, et al
   Clinical characteristics and outcomes of COVID-19-Associated acute encephalopathy in pediatric patients during the Omicron wave in beijing: a single-center prospective study.
   BMC Pediatr. 2025;25:688.
   PubMed         Abstract available
   
   
8. LIU Z, Li M, Lv J, Wang Y, et al
   Impact of COVID-19 infection on the sleep of infants and toddlers.
   BMC Pediatr. 2025;25:689.
   PubMed         Abstract available
   
   

   
   Cell

9. PEREIRA NETO TA, Zmasek C, Avalos L, Sidney J, et al
   Highly conserved Betacoronavirus sequences are broadly recognized by human T cells.
   Cell. 2025;188:5653-5665.
   PubMed         Abstract available
   
   

   
   J Immunol

10. BYRNE J, Gaillard CM, Gu L, Garcia-Leon A, et al
    Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contacts.
    J Immunol. 2025;214:2238-2243.
    PubMed         Abstract available
    
    

    
    J Virol

11. BAMUNUARACHCHI G, Vaddadi K, Liang Y, Zhu Z, et al
    Tankyrases positively regulate influenza A virus replication via type I interferon response.
    J Virol. 2025 Oct 2:e0129825. doi: 10.1128/jvi.01298.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

12. RUSS S, Nogareda F, Regan AK, Benedetti E, et al
    Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness - Eight Southern Hemisphere Countries, March-September 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:570-578.
    PubMed         Abstract available
    
    
13. REINHART K, Huang S, Kniss K, Reed C, et al
    Influenza-Associated Pediatric Deaths - United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:565-569.
    PubMed         Abstract available
    
    
14. FAZAL A, Harker EJ, Neelam V, Olson SM, et al
    Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy - United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:556-564.
    PubMed         Abstract available
    
    

    
    N Engl J Med

15. ZAR HJ, Simoes EAF, Madhi SA, Ramilo O, et al
    Clesrovimab for Prevention of RSV Disease in Healthy Infants.
    N Engl J Med. 2025 Sep 17. doi: 10.1056/NEJMoa2502984.
    PubMed         Abstract available
    
    

    
    Pediatrics

16. REES CA, Hall M, Ramgopal S, Badaki-Makun O, et al
    Variations in Medical Clearance Testing for Mental Health Emergency Department Visits.
    Pediatrics. 2025;156:e2025071007.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

17. BEREGI S, Parag KV
    Optimal algorithms for controlling infectious diseases in real time using noisy infection data.
    PLoS Comput Biol. 2025;21:e1013426.
    PubMed         Abstract available
    
    
18. BACKER JA, Klinkenberg D, Miura F, Wallinga J, et al
    Estimating the effectiveness of non-pharmaceutical interventions against COVID-19 transmission in the Netherlands.
    PLoS Comput Biol. 2025;21:e1013502.
    PubMed         Abstract available
    
    
19. LOOKER J, Rock KS, Dyson L
    Identifying COVID-19 peaks using early warning signals.
    PLoS Comput Biol. 2025;21:e1013524.
    PubMed         Abstract available
    
    

    
    PLoS Med

20. LEWIS BR, Hendrick J, Byrne K, Odette M, et al
    Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.
    PLoS Med. 2025;22:e1004519.
    PubMed         Abstract available
    
    

    
    PLoS One

21. MARTINS TCF, Pereira AMM, Machado CV, de Freitas CM, et al
    Comparative analysis of the lethality pattern of Covid-19 and the response of BRICS countries to the pandemic in the context of multilateralism: An ecological study.
    PLoS One. 2025;20:e0332883.
    PubMed         Abstract available
    
    
22. ABI-RIZK A
    The impact of the COVID-19 pandemic on public trust in science.
    PLoS One. 2025;20:e0328075.
    PubMed         Abstract available
    
    
23. WANG L, Li P, Li J, Chen M, et al
    Emerging horizons: A Rainbow Model for the sustainable implementation of Rain Classroom in vocational nursing education.
    PLoS One. 2025;20:e0331848.
    PubMed         Abstract available
    
    
24. MITCHELL HJ, McShane CM, Hawkins ST, Lohfeld L, et al
    Impact of COVID-19 on breast cancer patients and services in a UK region: Protocol for a mixed methods study.
    PLoS One. 2025;20:e0333288.
    PubMed         Abstract available
    
    
25. SEFAH IA, Ofori P, Hutton-Nyameaye A, Yamoah P, et al
    COVID-19 vaccine hesitancy and its predictors among healthcare workers in a tertiary hospital in Ghana: A cross-sectional survey.
    PLoS One. 2025;20:e0333412.
    PubMed         Abstract available
    
    
26. JORDAN S, Bottger SJ, Zinn S
    The persuasiveness of different sources of information on the decision to vaccinate. A cross-sectional study in Germany during the pandemic at the turn of the year 2021/2022.
    PLoS One. 2025;20:e0333268.
    PubMed         Abstract available
    
    
27. FORTUNATO P, Lombini A
    Behind political affiliation: How moral values, identity politics, and party loyalty have affected COVID-19 vaccination.
    PLoS One. 2025;20:e0330881.
    PubMed         Abstract available
    
    
28. CHEMAITELLY H, Ayoub HH, Coyle P, Tang P, et al
    Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An integrated epidemiological and economic analysis.
    PLoS One. 2025;20:e0331654.
    PubMed         Abstract available
    
    
29. ANDREI NS, Elena-Sabina T, Silviu-Mihail T, Ana-Iolanda V, et al
    Layers of exposure risk management measures for the prevention and control of infections of healthcare workers treating COVID-19 patients.
    PLoS One. 2025;20:e0332804.
    PubMed         Abstract available
    
    
30. WANG YJ, Su N, Jiang JH, Xu GP, et al
    Paxlovid plus glucocorticoids treatment in severe Omicron infected patients with hypoxaemia: A prospective multiple-center cohort study.
    PLoS One. 2025;20:e0328929.
    PubMed         Abstract available
    
    
31. RAY S, Alberuni S, Schonhuth A
    A graph neural network-based approach for predicting SARS-CoV-2-human protein interactions from multiview data.
    PLoS One. 2025;20:e0332794.
    PubMed         Abstract available
    
    
32. BUNN D, Zhang W, Smith N, Jimoh O, et al
    Minimising the impact of infectious outbreaks on resident quality of life: A qualitative proof of concept study using the Adult Social Care Outcomes Toolkit (ASCOT).
    PLoS One. 2025;20:e0316424.
    PubMed         Abstract available
    
    
33. ANDREWS K, Stoneley R, Eckl K
    Learn!Bio-A time-limited cross-sectional study on biosciences students' pathway to resilience during and post the Covid-19 pandemic at a UK university from 2020-2023 and insights into future teaching approaches.
    PLoS One. 2025;20:e0300824.
    PubMed         Abstract available
    
    
34. TOGEL J, Kuhbandner C
    COVID-19 vaccinations among German university students: The role of fear of COVID-19 and risk assessment.
    PLoS One. 2025;20:e0333082.
    PubMed         Abstract available
    
    
35. EL MAALOUF JM, Ghoche MT, Dunya G
    Trends in pediatric cochlear implants: The dual impact of COVID-19 and Lebanon's crisis.
    PLoS One. 2025;20:e0331234.
    PubMed         Abstract available
    
    
36. FILIMONOVIC J, Stevanovic M, Gazibara T, Saponjic V, et al
    Utilization of psychotropic drugs in Serbia from 2006 to 2021: Patterns before and during the COVID-19 pandemic.
    PLoS One. 2025;20:e0330749.
    PubMed         Abstract available
    
    
37. HOHMANN M, Coscia M
    Estimating affective polarization on a social network.
    PLoS One. 2025;20:e0328210.
    PubMed         Abstract available
    
    
38. ALMEIDA IDS, Ferreira LGJ, Vaz MA, Cipriano Junior G, et al
    Fatigue and neuromuscular function in long COVID: A one-year follow-up study.
    PLoS One. 2025;20:e0332242.
    PubMed         Abstract available
    
    
39. ALOTAIBI T, Morales L
    Sectoral sensitivity of the Kuwait stock market to a dual shock.
    PLoS One. 2025;20:e0331384.
    PubMed         Abstract available
    
    
40. GOODMAN SH, Altamirano J, Burns J, Sarnquist CS, et al
    Associations of SARS-CoV-2 PCR positivity with clinical symptoms and race/ethnicity: The household transmission study.
    PLoS One. 2025;20:e0332819.
    PubMed         Abstract available
    
    
41. WIGGINS M, Varughese M, Rafferty E, van Katwyk S, et al
    The decision uncertainty toolkit: Risk measures and visual outputs to support decision making during public health crises.
    PLoS One. 2025;20:e0332522.
    PubMed         Abstract available
    
    
42. GOLPASAND S, Ghovvati S, Pezeshkian Z
    Exploring the molecular and biological mechanisms of host response in chickens infected with highly pathogenic avian influenza virus (H5N1): An integrative transcriptomic analysis.
    PLoS One. 2025;20:e0332689.
    PubMed         Abstract available
    
    
43. TAN Y, Bayoumi I, Knox B, Cole M, et al
    Understanding social inclusion: A directed content analysis.
    PLoS One. 2025;20:e0333666.
    PubMed         Abstract available
    
    
44. CHAUFAN C
    How did Ontario healthcare institutions implement and legitimize Covid-19 vaccine mandates? A qualitative multi?method study protocol.
    PLoS One. 2025;20:e0332589.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

45. FAN W, Zhang Y, Gautron L, Thomas DG, et al
    FGF21 acting on the noradrenergic nervous system protects against influenza virus infection.
    Proc Natl Acad Sci U S A. 2025;122:e2522045122.
    PubMed         Abstract available
    
    
46. 
    Correction for Yeh et al., Three things we can do now to reduce the risk of avian influenza spillovers.
    Proc Natl Acad Sci U S A. 2025;122:e2524485122.
    PubMed        
    
    
47. MORIYAMA M, Rodrigues G, Wang J, Jayewickreme R, et al
    Intranasal hemagglutinin protein boosters induce protective mucosal immunity against influenza A viruses in mice.
    Proc Natl Acad Sci U S A. 2025;122:e2422171122.
    PubMed         Abstract available
    
    
48. MARTINEZ-GONZALEZ B, Soria ME, de Avila AI, Somovilla P, et al
    SARS-CoV-2 mutant spectrum complexity is an epidemiologically evolvable trait.
    Proc Natl Acad Sci U S A. 2025;122:e2515706122.
    PubMed         Abstract available
    
    
49. VILLAREJO-TORRES M, Nombela-Diaz I, Munoz-Santos D, Ruiz-Yuste M, et al
    SARS-CoV-2-derived RNA replicons as safe and effective vaccines.
    Proc Natl Acad Sci U S A. 2025;122:e2516587122.
    PubMed         Abstract available
    
    
50. LV H, Teo QW, Pholcharee T, Liu W, et al
    Molecular divergence and convergence of mammalian antibody responses to the influenza virus hemagglutinin stem.
    Proc Natl Acad Sci U S A. 2025;122:e2510927122.
    PubMed         Abstract available
    
    
51. YANG Y, Li Y, Becker ST, Khan A, et al
    Molecular basis of SARS-CoV-2 proofreading enzyme-mediated resistance to remdesivir.
    Proc Natl Acad Sci U S A. 2025;122:e2519755122.
    PubMed         Abstract available
    
    

    
    Vaccine

52. YANG Z, Zhang S, Zhao Y, Ma X, et al
    A mosaic H3 subtype live attenuated influenza vaccine elicits broad immune responses to influenza a viruses.
    Vaccine. 2025;65:127776.
    PubMed         Abstract available
    
    
53. BREZNIK JA, Miller MS, Bowdish DME
    Rationalizing recommendations for influenza and COVID-19 vaccines.
    Vaccine. 2025;65:127775.
    PubMed         Abstract available
    
    
54. ZHANG CX, Quigley MA, Bankhead C, Varughese R, et al
    Ethnic inequities in childhood influenza vaccination coverage in England 2013-2021: An observational cohort study.
    Vaccine. 2025;65:127710.
    PubMed         Abstract available
    
    
55. CLARKE M, McMillan M, Giles LC, Riley K, et al
    The impact of obesity on influenza Vaccine immunogenicity: A systematic review.
    Vaccine. 2025;65:127794.
    PubMed         Abstract available
    
    

    
    Virology

56. ZHANG X, Guan L, Wang H, Liu J, et al
    Generation and application of novel DNA aptamers targeted to the nucleocapsid protein of the SARS-CoV-2.
    Virology. 2025;612:110688.
    PubMed         Abstract available
    
    
57. ZHANG L, Kempf A, Nehlmeier I, Chen N, et al
    Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variant.
    Virology. 2025;612:110675.
    PubMed         Abstract available
    
    
58. HE Z, Zhang J, Kuang S, Li S, et al
    Colloidal gold technology in viral diagnostics: Recent innovations, clinical applications, and future perspectives.
    Virology. 2025;612:110686.
    PubMed         Abstract available
    
    
59. TOBA S, Uemura K, Sanaki T, Kusakabe S, et al
    Synergistic antiviral activity of a cathepsin B/L inhibitor and a TMPRSS2 inhibitor against SARS-CoV-2 in vitro and in vivo.
    Virology. 2025;612:110661.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.